Neurological Discovery Accelerated

Novela Neurotech accelerates the discovery of effective cures
for a wide range of neurological conditions

01 Our mission

The future

Our Mission - Deliver innovative solutions that impact neurological care, and enhance patients quality of life.

Novela’s Neureka™ Technology Platform - Significantly reduces the clinical development time enabling medical companies to launch effective neurological therapies faster.

Our goal- Bring an end to brain diseases and thrive at forging new frontiers in neurological cures.

02 WE are

About us

We call it the Novela “Neureka™ Moment” - As our smart neurological implants and machine learning software simplifies and automates the data collection and analysis in clinical research.

This enables medical companies to accelerate the discovery and development of innovative treatments for a wide range of neurological conditions.

Ray Iskander, CEO


If you are interested in joining us we’re hiring
For more information info@novelaneuro.com

03 Team

Executive Team

Ray Iskander
CEO
Peter Mankowski
CTO
Salam Gabran
Director of Engineering
Mark Valentine
Sr VP Business Development
& IP Portfolio
Rick Dalgetty
Vice President of
Regulatory & Quality

Advisors

Dr. Jose Velazquez | The Ronin Institute
Michael Ricci | Biomedical Technology Consultant
Dr. Harold Wodlinger | Medical Device Consultant
Dr. George Ekladious | Principal Data Scientist
Dr. Nabil Wasily | Technology Advisor

04 Technology

LIMITLESS POTENTIAL FOR GENERATIONS TO COME

Novela’s Neureka™ Technology Platform - simplifies and accelerates the discovery and development of neurological therapies based on neurostimulation.

Medical companies - can now quickly setup large clinical trials, with their own parameters and with unlimited data points. Neureka™ processes tons of data, and test out multiple possible therapies in parallel, accelerating the discovery of new cures without any human intervention.

The Future - Novela’s patented smart probe based technology will be used to enhance human brain functions by enabling two-way connectivity with cloud computing technologies; this will increase our memory, enable internet access and speed up thought processes.

05 News

Novela Inaugurates R&D Center

Based in Ontario, Canada
R&D Hub will facilitate collaboration with CRANIA and access to tier-1 talent in the Waterloo and Toronto areas.
January, we opened our research and development (R&D) center in Waterloo, Canada. Working in concert with the California headquarters, the center will focus on the advancement of the fabrication process of Novela’s neural implant devices.
Headed by Salam Gabran, Director of Engineering, the office is staffed by a team with impressive prior experience in medical devices microfabrication.

In The Press

Novela’s hometown newspaper the Alameda Sun featured us in their Thursday 1/24/19 issue.
“Novela’s long-term vision is to extend memory and brain processing speed, and even to add built-in cloud connectivity as well as expand human senses.” Read more
Peter Mankowski, Chief Technical Officer, relocated from California for the first half of 2019 to help establish the center and assist Salam with recruitments.
“Toronto continues to draw upon world-class talent and cultivate a relentless entrepreneurial spirit. Incubators like MaRS and Innovation Guelph, as well as leading medical R&D centers like the University Health Network (UHN), and Ontario Brain Institute (OBI). Novela plans to establish a strong foothold in Ontario, and plans to collaborate with the Center for Advancing Neurotechnological Innovation to Application, CRANIA™,” says Ray Iskander, Novela’s CEO.

In The Spotlight

Mark Valentine, Senior VP, Business Development & IP Portfolio
“I’ve witnessed firsthand the need for medical devices and treatments in those regions less fortunate than the western world. I think that’s why I’m so attracted to medical devices and technology companies.” Read more
img
img

06 Career

Work with us

Why choose us
We are building a multidisciplinary team passionate about making a major impact. We are looking for exceptional people with proven track records, especially in building high-precision medical devices as well as scalable fail-safe software applications.
Interested In Working For Novela?
We have positions available in San Francisco and Toronto.
Contact us for more details at

07 BLOG

Neural Notions

May 21, 2019
Parkinson’s Disease
Parkinson’s disease (PD) is a neurological disorder that...
Read more
May 13, 2019
Epilepsy III
From predicting seizures to controlling them...
Read more
February 01, 2019
Epilepsy II
Seizure anticipation would stop seizures, but are ictal events really predictable? Read more
January 11, 2019
Epilepsy I
In spite of antiepileptic drugs, about 30% of patients still have pharmaco-resistant seizures... Read more
December 05, 2018
A Brief Overview of Deep Brain Stimulation
Story of electrical stimulation of the nervous system has a long history...
Read more
June 07, 2017
Dynamiceuticals: The Next Stage in Personalized Medicine
Novela Neurostimulation

08 Contact

Contact us

Or send us a note.

Tell us what you need —

maybe we can help.

Subscribe to our newsletter

Locations

Corporate Office

San Francisco

1101 Marina Village Pkwy, Suite 201, Alameda,

California, 94501, USA

Research Center

Ontario

180 Northfield Dr West, unit 4

Waterloo, N2L 0C7, ON, Canada

info@novelaneuro.com

Locations

Corporate Office

San Francisco

1101 Marina Village Pkwy, Suite 201, Alameda,

California, 94501, USA

Research Center

Ontario

180 Northfield Dr West, unit 4

Waterloo, N2L 0C7, ON, Canada

info@novelaneuro.com